Global Gastrointestinal (GI) Stents Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Biliary Stent, Duodenal Stent, Colonic Stent, Pancreatic Stent, and Esophageal Stent.

By Application;

Biliary Disease, Colorectal Cancer, Stomach Cancer, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn946121545 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Gastrointestinal (GI) Stents Market (USD Million), 2021 - 2031

In the year 2023, the Global Gastrointestinal (GI) Stents Market was valued at USD 1,787.04 million. The size of this market is expected to increase to USD 2,267.47 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 3.5%.

The global gastrointestinal (GI) stents market stands as a critical component of medical care, offering minimally invasive solutions for patients suffering from gastrointestinal disorders. GI stents, comprising self-expandable metal stents (SEMS) and plastic stents, play a pivotal role in the management of various conditions such as colorectal cancer, esophageal cancer, gastroduodenal obstruction, and benign strictures. These devices are designed to alleviate symptoms, restore luminal patency, and provide palliative care, thereby improving the quality of life for patients facing debilitating gastrointestinal ailments.

As the prevalence of gastrointestinal diseases continues to rise worldwide due to factors such as aging populations, changing dietary habits, and increasing incidence of risk factors such as obesity and smoking, the demand for GI stents is witnessing a steady ascent. Moreover, advancements in stent design, materials, and delivery systems, coupled with the growing adoption of endoscopic procedures and minimally invasive techniques, are further propelling market growth. Challenges such as complications associated with stent placement, stringent regulatory requirements, and pricing pressures pose significant hurdles for market players. Nonetheless, with ongoing research and development efforts aimed at enhancing stent efficacy, safety, and biocompatibility, the global GI stents market is poised for continued expansion and innovation in the years ahead.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Application
    3. Market Snapshot, By Region
  4. Global Gastrointestinal (GI) Stents Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Prevalence of Gastrointestinal Disorders

        2. Advancements in Stent Technology

        3. Aging Population and Increasing Endoscopic Procedures

      2. Restraints
        1. Availability of Alternative Treatment Modalities

        2. Stringent Regulatory Approval Processes

        3. Complications Associated with Stenting Procedures

      3. Opportunities
        1. Expanding Geriatric Population

        2. Increasing Preference for Minimally Invasive Procedures

        3. Growing Prevalence of Gastrointestinal Disorders

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Gastrointestinal (GI) Stents Market, By Product, 2021 - 2031 (USD Million)
      1. Biliary Stent

      2. Duodenal Stent

      3. Colonic Stent

      4. Pancreatic Stent

      5. Esophageal Stent

    2. Global Gastrointestinal (GI) Stents Market, By Application, 2021 - 2031 (USD Million)
      1. Biliary Disease

      2. Colorectal Cancer

      3. Stomach Cancer

      4. Others

    3. Global Gastrointestinal (GI) Stents Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Olympus Corporation
      2. Boston Scientific Corporation
      3. Hobbs Medical Inc.
      4. Conmed Corporation
      5. Becton Dickinson and Company
  7. Analyst Views
  8. Future Outlook of the Market